Form 8-K - Current report:
SEC Accession No. 0001171843-21-008236
Filing Date
2021-12-01
Accepted
2021-12-01 08:30:13
Documents
14
Period of Report
2021-11-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_120121.htm   iXBRL 8-K 24883
2 EXHIBIT 2.1 exh_21.htm EX-2.1 411862
3 EXHIBIT 99.1 exh_991.htm EX-99.1 9431
  Complete submission text file 0001171843-21-008236.txt   717308

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE poai-20211124.xsd EX-101.SCH 3040
5 XBRL LABEL FILE poai-20211124_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE poai-20211124_pre.xml EX-101.PRE 22369
7 EXTRACTED XBRL INSTANCE DOCUMENT f8k_120121_htm.xml XML 3600
Mailing Address 2915 COMMERS DRIVE, SUITE 900 EAGAN MN 55121
Business Address 2915 COMMERS DRIVE, SUITE 900 EAGAN MN 55121 651-389-4800
Predictive Oncology Inc. (Filer) CIK: 0001446159 (see all company filings)

IRS No.: 331007393 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36790 | Film No.: 211461511
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies